Novozymes acquires enzyme business from Iogen

Novozymes says it will acquire Iogen Bio-Products, the industrial enzyme business of Iogen (Ottawa, ON) for C$67.5 million ($67.6 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities, and know-how. The acquisition does not include the purchase of process technology assets that relate to Iogen’s second-generation biofuels business. The acquisition is expected to be completed by the end of this month. Iogen...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers